SRC is still affecting a meaningful population of patients with systemic sclerosis, so a vigilant diagnosis and therapy is needed to prevent adverse outcomes and enhance survival. Seminars in Arthritis and Rheumatism, 02/27/2015. (Also see Scleroderma Renal Crisis)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.